Press Release

  ThirtyFiveBio Emerges From Stealth with Presentation of First Data from GPR35 Antagonist Program at American Association for Cancer Research (AACR) Annual Meeting 2023    Third Company Created by M:M Bio and Jointly Incubated by Canaan Partners has Raised $20 Million to Date  Pioneering a New Precision Medicine Approach to Gastrointestinal Diseases and Cancers through...